Next Article in Journal
Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea
Previous Article in Journal
Percutaneous Cementoplasty of Lytic Metastasis in Left Acetabulum
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada

Prostate Bone Metastases Clinic, Department of Medical Oncology, Toronto–Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2007, 14(1), 9-12; https://doi.org/10.3747/co.2007.101
Submission received: 1 November 2006 / Revised: 1 December 2006 / Accepted: 1 January 2007 / Published: 1 February 2007

Abstract

Prostate cancer is the most common non-skin malignancy in men. Almost all men who die from prostate cancer have hormone-refractory prostate cancer with metastasis to bone. Emerging supportive treatments—including chemotherapy, bisphosphonates, and surgery—require integration that is optimized in a multidisciplinary setting. A multidisciplinary clinic for bone metastases has been in place at Toronto–Sunnybrook Regional Cancer Centre since 1999, combining orthopedic surgery, radiation oncology, interventional radiology, and palliative medicine for all patients with bone metastases. The addition of a prostate-focused multidisciplinary clinic integrates these services for patients with advanced prostate cancer.
Keywords: prostate; bone metastases; prostate clinic; skeletal-related events; hormone-refractory; multidisciplinary; Toronto–Sunnybrook Regional Cancer Centre; zoledronic acid; bisphosphonate prostate; bone metastases; prostate clinic; skeletal-related events; hormone-refractory; multidisciplinary; Toronto–Sunnybrook Regional Cancer Centre; zoledronic acid; bisphosphonate

Share and Cite

MDPI and ACS Style

Goh, P.; Harris, K.; Napolskikh, J.; Chow, E.; Sinclair, E.; Emmenegger, U.; Lemon, S.; Yee, A.; Wynnychuk, L.; Myers, J.; et al. New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada. Curr. Oncol. 2007, 14, 9-12. https://doi.org/10.3747/co.2007.101

AMA Style

Goh P, Harris K, Napolskikh J, Chow E, Sinclair E, Emmenegger U, Lemon S, Yee A, Wynnychuk L, Myers J, et al. New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada. Current Oncology. 2007; 14(1):9-12. https://doi.org/10.3747/co.2007.101

Chicago/Turabian Style

Goh, P., K. Harris, J. Napolskikh, E. Chow, E. Sinclair, U. Emmenegger, S. Lemon, A. Yee, L. Wynnychuk, J. Myers, and et al. 2007. "New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada" Current Oncology 14, no. 1: 9-12. https://doi.org/10.3747/co.2007.101

APA Style

Goh, P., Harris, K., Napolskikh, J., Chow, E., Sinclair, E., Emmenegger, U., Lemon, S., Yee, A., Wynnychuk, L., Myers, J., Danjoux, C., & Ko, Y., (The Bone Metastases Site Group). (2007). New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada. Current Oncology, 14(1), 9-12. https://doi.org/10.3747/co.2007.101

Article Metrics

Back to TopTop